Cargando…

Challenges in evaluating treatments for COVID-19: The case of in-hospital anticoagulant use and the risk of adverse outcomes

Anticoagulants are a potential treatment for the thrombotic complications resulting from COVID-19. We aimed to determine the association between anticoagulant use and adverse outcomes among hospitalized patients with COVID-19. We used data from the COVID-19 International Collaborative Research Proje...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Ya-Hui, Oh, In-Sun, Jeong, Han Eol, Platt, Robert W., Douros, Antonios, Shin, Ju-Young, Filion, Kristian B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729259/ https://www.ncbi.nlm.nih.gov/pubmed/36506517 http://dx.doi.org/10.3389/fphar.2022.1034636

Ejemplares similares

Immeasurable Time Bias in Self-controlled Designs: Case-crossover, Case-time-control, and Case-case-time-control Analyses
por: Jeong, Han Eol, et al.
Publicado: (2023)

Association of adverse respiratory events with sodium-glucose cotransporter 2 inhibitors versus dipeptidyl peptidase 4 inhibitors among patients with type 2 diabetes in South Korea: a nationwide cohort study
por: Jeong, Han Eol, et al.
Publicado: (2023)

Heterogeneous distributions in clinical events preceding anticoagulant treatment nonpersistence in patients with venous thromboembolism stratified by active cancer: A nationwide cohort study
por: Yoon, Dongwon, et al.
Publicado: (2023)

Real-world data emulating randomized controlled trials of non-vitamin K antagonist oral anticoagulants in patients with venous thromboembolism
por: Yoon, Dongwon, et al.
Publicado: (2023)

Predictors of oral anticoagulant-associated adverse events in seniors transitioning from hospital to home: a retrospective cohort study protocol
por: Benipal, Harsukh, et al.
Publicado: (2020)

Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study
por: Douros, Antonios, et al.
Publicado: (2018)

Observational Studies of Drug Safety in Multi-Database Studies: Methodological Challenges and Opportunities
por: Platt, Robert W., et al.
Publicado: (2016)

Safety of Dabigatran as an Anticoagulant: A Systematic Review and Meta-Analysis
por: Zhou, Ya, et al.
Publicado: (2021)

Tele-pharmacy Anticoagulation Clinic During COVID-19 Pandemic: Patient Outcomes
por: Al Ammari, Maha, et al.
Publicado: (2021)

Neonatal and maternal adverse outcomes and exposure to nonsteroidal anti-inflammatory drugs during early pregnancy in South Korea: A nationwide cohort study
por: Choi, Eun-Young, et al.
Publicado: (2023)

The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety
por: Ekor, Martins
Publicado: (2014)

Cannabidiol Drugs Clinical Trial Outcomes and Adverse Effects
por: Pauli, Christopher S., et al.
Publicado: (2020)

Adverse Drug Reactions in Hospitalized Patients: Results of the FORWARD (Facilitation of Reporting in Hospital Ward) Study
por: Giardina, Claudia, et al.
Publicado: (2018)

Extended anticoagulation for VTE: what evidence justifies it?
por: Walia, Anushka, et al.
Publicado: (2023)

Effectiveness and safety of direct oral anticoagulants with antiplatelet agents in patients with venous thromboembolism: A multi‐database cohort study
por: Douros, Antonios, et al.
Publicado: (2022)

Serum Adiponectin is Associated with Adverse Outcomes of Asthma in Men but Not in Women
por: Sood, Akshay, et al.
Publicado: (2011)

Global COVID‐19 pandemic and reporting behavior ‐ An analysis of the Food and Drug Administration adverse events reporting system
por: Dörks, Michael, et al.
Publicado: (2021)

Association of sodium-glucose cotransporter 2 inhibitors with post-discharge outcomes in patients with acute heart failure with type 2 diabetes: a cohort study
por: Park, Sohee, et al.
Publicado: (2023)

Hospitalizations Due to Adverse Drug Events in the Elderly—A Retrospective Register Study
por: Laatikainen, Outi, et al.
Publicado: (2016)

Ocular adverse events associated with anti-VEGF therapy: A pharmacovigilance study of the FDA adverse event reporting system (FAERS)
por: Ma, Pan, et al.
Publicado: (2022)

Bleeding in women with venous thromboembolism during pregnancy: A systematic review of the literature
por: Simard, Camille, et al.
Publicado: (2022)

Grand Challenges in Pharmacoeconomics and Health Outcomes
por: Dubois, Dominique J.
Publicado: (2010)

Risk of mortality associated with concomitant antidepressant and benzodiazepine therapy among patients with depression: a population-based cohort study
por: Jeong, Han Eol, et al.
Publicado: (2020)

A study of the regional differences in propacetamol-related adverse events using VigiBase data of the World Health Organization
por: Jeong, Han Eol, et al.
Publicado: (2022)

Evaluation of Adverse Drug Reactions in Paediatric Patients: A Retrospective Study in Turkish Hospital
por: Khan, Zakir, et al.
Publicado: (2021)

Evaluation of the Effect of Lime Fruit Juice on the Anticoagulant Effect of Warfarin
por: Adepoju, GKA, et al.
Publicado: (2010)

Perioperative management of neurosurgical patients receiving chronic anticoagulation therapy
por: Zakaryan, Arman
Publicado: (2014)

Construction of a risk scoring system using clinical factors and RYR2 polymorphisms for bleeding complications in patients on direct oral anticoagulants
por: Jang, Eun Jeong, et al.
Publicado: (2023)

Socioeconomic disparities in Korea by health insurance type during the COVID-19 pandemic: a nationwide study
por: Jeong, Han Eol, et al.
Publicado: (2021)

Immunological Changes in Pregnancy and Prospects of Therapeutic Pla-Xosomes in Adverse Pregnancy Outcomes
por: Devvanshi, Himadri, et al.
Publicado: (2022)

Adverse drug reactions in an ageing PopulaTion (ADAPT) study: Prevalence and risk factors associated with adverse drug reaction-related hospital admissions in older patients
por: Cahir, Caitriona, et al.
Publicado: (2023)

Efficacy and safety of anticoagulation in atrial fibrillation patients with intracranial hemorrhage: A systematic review and meta-analysis
por: Zhou, Qiang, et al.
Publicado: (2023)

Corrigendum: Evaluation of Adverse Drug Reactions in Paediatric Patients: A Retrospective Study in Turkish Hospital
por: Khan, Zakir, et al.
Publicado: (2021)

The Transcultural Adaptation and Validation of the Chinese Version of the Duke Anticoagulation Satisfaction Scale
por: Wu, Yibo, et al.
Publicado: (2022)

Changes in the Gut Microbiota May Affect the Clinical Efficacy of Oral Anticoagulants
por: Chen, Wenjun, et al.
Publicado: (2022)

Risk of major adverse events associated with gabapentinoid and opioid combination therapy: A systematic review and meta-analysis
por: Hahn, Jongsung, et al.
Publicado: (2022)

Physician–Pharmacist Collaborative Clinic Model to Improve Anticoagulation Quality in Atrial Fibrillation Patients Receiving Warfarin: An Analysis of Time in Therapeutic Range and a Nomogram Development
por: Wang, Na, et al.
Publicado: (2021)

Female reproductive tract pain: targets, challenges, and outcomes
por: Jobling, Phillip, et al.
Publicado: (2014)

Major Bleeding Risk in Atrial Fibrillation Patients Co-Medicated With Non-Vitamin K Oral Anticoagulants and Antipsychotics
por: Chen, Chiung-Mei, et al.
Publicado: (2022)

Evaluation of a Pharmacist-Led Remote Warfarin Management Model Using a Smartphone Application (Yixing) in Improving Patients’ Knowledge and Outcomes of Anticoagulation Therapy
por: Jiang, Shudan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qhsnkcss0v13clg9s4n5fgtb7p